UBS raised the firm’s price target on American Healthcare REIT (AHR) to $56 from $51 and keeps a Buy rating on the shares.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $55 from $47 at Scotiabank
- American Healthcare REIT price target raised to $55 from $43 at KeyBanc
- American Healthcare REIT price target raised to $54 from $45 at RBC Capital
- American Healthcare REIT price target raised to $60 from $50 at Citizens JMP
- American Healthcare REIT Reports Robust Earnings Growth